Delivery Order SPE2DB20D2104-SPE2DB25FMBKQ

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $2,072.16. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. This appears to be a delivery order contract, with a firm fixed-price pricing type. The contract is not set aside for any...
This federal contract award is for delivery of the pharmaceutical product Mounjaro (7.5 mg/0.5 mL pen) to the Defense Logistics Agency (DLA). The $36,978.47 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024, with a completion date of October 25, 2024. The contract is a delivery order, not associated with a set-aside designation, and is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Mounjaro 2.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,792.65, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 21, 2024. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of August 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
The federal contract award detailed is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $6,963.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with a completion date of November 13, 2024. This delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical that provides a wide range of...
The federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pen (0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $2,630 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,111.27, is a Firm Fixed Price Delivery Order for the supply of Mounjaro 10 mg/0.5 ml pens. It has an ultimate completion date of July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $2,253.38 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor supporting the U.S. government. The contract has an ultimate completion date of May 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, for the delivery of Mounjaro 5 mg/0.5 ml pens. The contract has a firm fixed price of $3,156.00 and a period of performance through March 19, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Mounjaro 7.5 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $1,632.54 and has an ultimate completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens worth $2,988.06 to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMBKQ
    Delivery Order

This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The $3,143.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024.

The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 1/27/25, 1:18 PM